Noble Wellness Private Limited Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Noble Wellness Private Limited Pharmaceutical Export Portfolio Dataset — 2 Products, $457.5K FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Noble Wellness Private Limited — Pharmaceutical Exporter Profile (2026) | 2 Products, $457.5K Trade | TransData Nexus

Noble Wellness Private Limited

Indian Pharmaceutical Exporter · Respiratory Specialist · $457.5K Total Trade · DGFT Verified

Noble Wellness Private Limited is an Indian pharmaceutical exporter with a total trade value of $457.5K across 2 products in 1 therapeutic categories. Based on 18 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Budesonide ($372.9K), Ipratropium ($84.6K), .

Noble Wellness Private Limited — Export Portfolio & Destination Treemap

Noble Wellness Private Limited pharmaceutical export portfolio — 2 products across 1 therapeutic categories. Source: Indian Customs (DGFT).

Who is Noble Wellness Private Limited? — Company Overview & Market Position

Noble Wellness Private Limited is an Indian pharmaceutical company established on April 24, 2012, in New Delhi, Delhi, India. The company is registered under the Corporate Identification Number (CIN) U24232DL2012PTC234745. It operates as a private limited company, classified as a non-government entity, and is unlisted on stock exchanges. The authorized capital stands at ₹0.50 million, with a paid-up capital of ₹0.10 million.

The registered office is located at Dtj810, 8th Floor, DLF Tower-B, DDA District Centre, Jasola, New Delhi, Delhi, 110025. The company specializes in the manufacturing and export of pharmaceutical formulations, including tablets, capsules, syrups, injections, and other dosage forms. Their product portfolio also encompasses herbal formulations, dietary supplements, and nutraceuticals.

What Does Noble Wellness Private Limited Export? — Product Portfolio Analysis

Top Products by Export Value

1Budesonide$372.9K 2Ipratropium

Product Portfolio — Top 2 by Export Value

Noble Wellness Private Limited exports 2 pharmaceutical products across 1 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Budesonide	Respiratory	$372.9K	10	0.2%	12
2	Ipratropium	Respiratory	$84.6K	8	0.1%	14

Noble Wellness Private Limited exports 2 pharmaceutical products across 1 therapeutic categories with a total export value of $457.5K. The top category is Respiratory (100.0% of portfolio), indicating a concentrated portfolio with the top 5 products accounting for 100.0% of total export value.

Noble Wellness Private Limited — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

Noble Wellness Private Limited operates manufacturing facilities in India, with the registered office situated in New Delhi. While specific details regarding the locations and capacities of their manufacturing plants are not publicly disclosed, the company emphasizes its commitment to quality and compliance with international standards. They hold certifications such as WHO-GMP and ISO, indicating adherence to stringent manufacturing practices.

3Key Leadership

The leadership team at Noble Wellness Private Limited comprises:

Archna Ratra: Director since April 24, 2012.
Sanjay Kumar Ratra: Director since April 24, 2012.

The company does not publicly disclose the positions of Chief Executive Officer (CEO) or Chief Financial Officer (CFO). The directors are actively involved in the company's strategic direction and operations.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Noble Wellness Private Limited Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Noble Wellness Private Limited's export data indicates shipments to various international markets, including Mongolia, Afghanistan, and China. However, specific regulatory approvals or market access statuses in the United States, European Union, United Kingdom, Australia, and Japan are not publicly available. The company holds WHO-GMP and ISO certifications, which may facilitate entry into certain regulated markets.

2Emerging Markets

The company's export activities in Mongolia, Afghanistan, and China suggest a presence in emerging markets. While specific details regarding WHO prequalification or other certifications enabling access to these markets are not disclosed, the company's adherence to international standards may support its expansion in these regions.

3Geographic Strategy

Noble Wellness Private Limited's export data indicates shipments to various international markets, including Mongolia, Afghanistan, and China. However, specific details regarding the company's geographic diversification strategy are not publicly available. The company's focus on international certifications such as WHO-GMP and ISO suggests a strategic direction towards meeting global quality standards.

Noble Wellness Private Limited — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

Specific information regarding FDA facility registrations, approved Abbreviated New Drug Applications (ANDAs), Drug Master File (DMF) filings, or inspection history for Noble Wellness Private Limited is not publicly available. The company's export data indicates shipments to various international markets, including Mongolia, Afghanistan, and China. However, details regarding FDA approvals or market access are not disclosed.

2WHO & EU GMP

Noble Wellness Private Limited holds WHO-GMP and ISO certifications, indicating compliance with international manufacturing standards. Specific details regarding EU GMP certificates or EDQM status are not publicly available.

3CDSCO & Indian Regulatory

The company is registered with the Ministry of Corporate Affairs under CIN U24232DL2012PTC234745. Specific details regarding CDSCO manufacturing licenses, state drug controller approvals, or export No Objection Certificates (NOCs) are not publicly disclosed.

Noble Wellness Private Limited — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

Noble Wellness Private Limited operates in the pharmaceutical manufacturing and export sector, competing with other Indian pharmaceutical companies in the same domain. Specific market share comparisons or head-to-head analyses are not publicly available. The company's focus on international certifications such as WHO-GMP and ISO may provide a competitive edge in global markets.

2Key Differentiators

Noble Wellness Private Limited differentiates itself through its robust portfolio of both prescription and over-the-counter products, including tablets, capsules, syrups, injections, and more. The company also offers a wide range of herbal formulations, dietary supplements, and nutraceuticals. Additionally, their adherence to international standards, as evidenced by WHO-GMP and ISO certifications, underscores their commitment to quality and compliance.

3Strategic Position

Noble Wellness Private Limited's strategic direction appears to focus on manufacturing and exporting a diverse range of pharmaceutical formulations, including both prescription and over-the-counter products. The company's adherence to international standards such as WHO-GMP and ISO certifications suggests a commitment to quality and regulatory compliance. While specific details regarding future strategic plans are not publicly available, the company's existing certifications and product portfolio position it to cater to both generics and specialty markets.

Buyer Due Diligence Brief — Evaluating Noble Wellness Private Limited as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

Noble Wellness Private Limited's export data indicates shipments to various international markets, including Mongolia, Afghanistan, and China. The company's adherence to international standards, as evidenced by WHO-GMP and ISO certifications, suggests a reliable track record in manufacturing and exporting pharmaceutical products. However, specific details regarding export volume consistency and reliability indicators are not publicly available.

2Certifications to Verify

Importers should verify the following certifications to ensure product quality and regulatory compliance:

WHO-GMP Certification: Indicates compliance with World Health Organization Good Manufacturing Practices.
ISO Certification: Demonstrates adherence to international quality management standards.

These certifications can typically be verified by requesting copies from the supplier or checking with the certifying bodies.

3Due Diligence Checklist

Frequently Asked Questions — Noble Wellness Private Limited

How many pharmaceutical products does Noble Wellness Private Limited export from India?

Noble Wellness Private Limited exports 2 pharmaceutical products across 1 therapeutic categories. The top exports are Budesonide ($372.9K), Ipratropium ($84.6K). Total export value is $457.5K.

What is Noble Wellness Private Limited's total pharmaceutical export value?

Noble Wellness Private Limited's total pharmaceutical export value is $457.5K, based on 18 verified shipments recorded in Indian Customs (DGFT) data.

What therapeutic categories does Noble Wellness Private Limited cover?

Noble Wellness Private Limited exports across 1 therapeutic categories. The largest are Respiratory (100.0%, 2 products).

Get Full Noble Wellness Private Limited Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.